Can atrial fibrillation (AF) increase the risk of pulmonary embolism in older adults with additional risk factors such as immobility, cancer, or a history of deep vein thrombosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Atrial Fibrillation Cause Pulmonary Embolism?

Atrial fibrillation does not directly cause pulmonary embolism, but it is an independent risk factor for deep vein thrombosis (DVT) and subsequent PE, particularly in the setting of stroke, immobility, or other prothrombotic conditions. 1

The Mechanistic Relationship

AF as a Risk Factor for Venous Thromboembolism

  • AF is independently associated with increased DVT risk in stroke patients, where it was the only significant risk factor in multivariate analysis for venous thromboembolic complications 1, 2
  • The American Stroke Association identifies advanced age, immobility, paralysis of the lower extremity, severe paralysis, and atrial fibrillation as associated with increased risk of deep vein thrombosis in stroke patients 1
  • AF patients have a 6-7 fold increased risk of VTE during the first 30 days after AF diagnosis (40.2 vs 5.7 per 1000 person-years in men; 55.7 vs 6.6 in women), which decreases substantially after anticoagulation is initiated 3

The Bidirectional Association

  • PE and AF share common risk factors including advanced age, obesity, heart failure, and inflammatory states, making it difficult to establish pure causality 4
  • PE can trigger AF through right-sided pressure overload or inflammatory cytokines, while AF may lead to right atrial appendage clot formation and thereby PE 4
  • However, a large Swedish registry study found that after adjustment for age and comorbidity, AF without anticoagulation was not independently associated with increased PE risk (HR 1.03, CI 0.94-1.13) 5

Clinical Context: When AF Increases PE Risk

High-Risk Scenarios

In stroke patients with immobility:

  • Pulmonary embolism accounts for approximately 10% of deaths after stroke, and AF is a recognized risk factor in this population 1
  • The combination of AF plus immobility creates a particularly high-risk state for venous thromboembolism 1

In cancer patients:

  • The European Society of Cardiology notes that AF in cancer patients is associated with a two-fold higher risk of systemic thromboembolism 1
  • Cancer patients with new-onset AF have a two-fold increased risk of thromboembolism compared to those without AF 1

Early after AF diagnosis:

  • VTE risk is highest in the first 30 days after AF diagnosis before anticoagulation is typically initiated, then decreases substantially 3

Protective Factors

  • Patients with AF and PE have significantly lower incidence of DVT (21% vs 44% in controls), suggesting some PE cases in AF patients may originate from right atrial thrombi rather than leg veins 6
  • Anticoagulation for AF stroke prevention simultaneously reduces VTE risk, which explains why VTE rates normalize after 9 months of treatment 3

Clinical Implications for Management

Prophylaxis Considerations

  • Anticoagulants are effective in preventing DVT and PE among bedridden patients with recent stroke, and this is particularly important when AF is present 1
  • The American Stroke Association recommends prophylactic anticoagulation for stroke patients with AF who are immobilized 1

Risk Stratification

  • CHA2DS2-VASc score correlates with PE risk in AF patients and may be more sensitive than CHADS2 for predicting PE 4, 6
  • Consider cancer type, stage, immobility, and history of DVT when assessing PE risk in AF patients, as these factors have additive effects 1

Key Clinical Pitfalls

  • Do not assume AF alone causes PE in the absence of other risk factors - the association is largely explained by shared comorbidities and age 5
  • Do not withhold anticoagulation in elderly AF patients due to PE concerns - therapeutic anticoagulation for AF stroke prevention simultaneously reduces VTE risk 3
  • Recognize that the first month after AF diagnosis carries the highest VTE risk before anticoagulation is established 3
  • In cancer patients with AF, bleeding risk may exceed thrombotic risk depending on cancer type, requiring individualized assessment 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Atrial fibrillation and risk of venous thromboembolism: a Swedish Nationwide Registry Study.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.